Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
Christine A Kiire, Rupal Morjaria, Anna Rudenko, Alexina Fantato, Lewis Smith, Amy Smith, Victor Chong Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Purpose: Pegaptanib has been shown to be effective in treating diabetic macular edema (DME). In the original Phas...
Main Authors: | Kiire CA, Morjaria R, Rudenko A, Fantato A, Smith L, Smith A, Chong V |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-12-01
|
Series: | Clinical Ophthalmology |
Subjects: | |
Online Access: | https://www.dovepress.com/intravitreal-pegaptanib-for-the-treatment-of-ischemic-diabetic-macular-peer-reviewed-article-OPTH |
Similar Items
-
Pegaptanib sodium for ocular vascular disease
by: Shukla Dhananjay, et al.
Published: (2007-01-01) -
CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB
by: M. Burova, et al.
Published: (2015-12-01) -
Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib
by: M. Burova, et al.
Published: (2013-02-01) -
Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor
by: Albert John Bromeo, et al.
Published: (2022-08-01) -
Primary treatment of diabetic macular edema
by: Tushar M Ranchod, et al.
Published: (2009-02-01)